Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243

Diabetologia

Volumn 39, Issue 10, 1996, Pages 1196-1200

  Kobayashi, T ^a   Oka, Y ^b   Katagiri, H ^c   Falornl, A ^d   Kasiiga, A ^e   Takei, I ^e   Nuakanishi, K ^a   Murase, T ^a   Kosaka, K ^a   Lernmark, A ^d,f  

^a TORANOMON HOSPITAL   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KEIO UNIVERSITY   (Japan)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoantibodies to glulamic acid decarboxylase (GAD); HLA; Insulin dependent diabetes mellitus; Islet cell antibodies; Mitochondrial gene mutation

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; MITOCHONDRIAL DNA; PANCREAS ISLET CELL ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD; DIABETES MELLITUS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; ONSET AGE; POINT MUTATION; REFERENCE VALUE; RISK FACTOR;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; DIABETES MELLITUS; DNA, MITOCHONDRIAL; FEMALE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; REFERENCE VALUES; RISK FACTORS;

EID: 0030256832     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02658506     Document Type: Article

References (35)

1. Kobayashi T, Itoh T, Kosaka K et al. (1987) Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 36: 510-517
2. Oka Y, Katagiri H, Yazaki Y et al. (1993) Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 342: 527-528
3. Lcu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1: 368-371
4. Reardon W, Ross RJM, Sweeney MG et al. (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-1379
5. Gerbitz KD (1993) Mitochondrial DNA defects in diabetes mellitus. Diabetologia 36: 578-579 (Letter)
6. Kadowaki T, Kadowaki H, Mori Y et al. (1994) Subtype of diabetes mellitus associated with a mutation in the mitochondrial gene. N Engl J Med 330: 962-968
7. Katagiri H, AsanoT, Ishihara H et al. (1994) Mitochondrial diabetes mellitus:prevalence and clinical characterization of diabetes due to mitochondria! tRNALcu(UuS) gene mutation in Japanese patients. Diabetologia 37: 504-510
8. Loveland B, Wang C-R, Yonekawa H et al. (1990) Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell 60: 971-980
9. Gerbitz KD (1992) Does the mitochondrial DNA play a role in the pathogenesis of diabetes? Diabetologia 35: 1181-1186 =
10. Lernmark A, Barmeier H, Dube S et al. (1991) Autoimmunity of diabetes. Endocrinol Metab Clin North Am 20: 589617
11. Warram JH, Krolewski AS, Gottlieb M et al. (1984) Difference in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311: 149-152
12. Thomas F, Baikau B, Vauzelle-Kervroedan V et al. (1994) Maternal effect and familial aggregation in NIDDM; The CODIAB study. Diabetes 43: 63-67
13. LEU(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 37: 818-825
14. Baekkcskov S, Aanstoot H-J, Christgau S et al.(1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
15. Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350
16. Kobayashi T, Tamemoto K, Nakanishi K et al. (1993) Immunogenctic and clinical characterization of slowly progressive IDDM. Diabetes Care 16: 780-788
17. Kobayashi T, Sugimoto T, Itoh Tetal. (1986) The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studies by indirect immunofluorescence and by a new method. Diabetes 35: 335-340
18. Boitard C, Bonifacio E, Bottazzo GF, Gleichrnann H, Molenaar T (1988) Immunology and diabetes workshop: report on the third international (stage 3) workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 31: 451-452
19. Gianani R, Puglicse A, Bonner-Weir S et al. (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41: 347-353
20. Timsit J, Caillat-Zucman S, Blonde! H, Chedin P, Bach JF, Boiiard C (1992) Islet ceil antibody heterogeneity among type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 792-795
21. Kobayashi T, Nakanishi K, Murase T, Kosaka K (1993) Subtype of islet cell antibodies and slowly progressive beta-cell failure. Diabetologia 36: 92 (Letter)
22. Kawasaki E,TakinoH, Yano M et al. (1994) Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86
23. Karlsen AE, Hagopian WA, Petersen JS et al. (1992) Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDMassociated 64,000 -Mr autoantibodies. Diabetes 41: 1355-1359
24. Falorni A, Grubin CE, Takei I et al. (1994) Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutarnic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19: 113-125
25. Schmidli RS, Colman PG, Bonifacio E et al. (1994) High level of concordance between assays for glutamic acid decarboxylase antibodies. Diabetes 43: 1005-1007
26. Nakanishi K. Kobayashi T, Miyashita H et al. (1990) Relationships among islet cell antibodies, residual B -cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of sensitive Cpeptide radioimmunoassay. Metabolism 39: 925-930
27. Bonifacio E, Bingley P, Shattock M et al. (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-153
28. Jenkins D, Mijovic C, Fletchcr J, Jacobs KH, Bradwell AR, Barnett AH (1990) Identification of susceptibility loci for type 1 (insulin-dependent) diabetes by trans-racial gene mapping. Diabetologia 33: 387-395
29. Hayakawa M. Ogawa T, Sugivama S et al. (1991) Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondria! DNA by administration of azidothymidine. Biochem Biophys Res Commun 176: 87-93
30. Hayakawa M, Hattori K, Sugiyama K et al. (1992) Age-associated oxygen damage and mutations in mitochondria! DNA in human hearts. Biochem Biophys Res Commun 189:979-985
31. Gerbitz KD, Gempe! K, Brdiczka D (1996) Mitochondria and diabetes: genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 45: 113-126
32. Cortopassi G, Wang E (1995) Modeling the effects of agerelated mtDNA mutation accumulation: complex I deficiency, Superoxide and cell death. Biochim Biophys Acta 1271:'l71-176
33. Okamoto H (1990) The molecular basis of experimental diabetes. In: Okamoto H (ed) The molecular biology of the islets of Langerhans, Cambridge University Press. Cambridge, pp 209-231
34. Nakanishi K, Kobayashi T, Miyashita H et al. (1993) Relationships among residual cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism 42: 196-203
35. Richter W, Seissler J, Northemann W et al. (1993) Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM. but not in stiff man-syndrome. Diabetes 42: 1642-1648